Geratherm Medical AG (GME.DE)
EUR 3.72
(2.76%)
EUR 3.72
(2.76%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.99 Million EUR | 257.6% |
| 2022 | 557.28 Thousand EUR | -92.1% |
| 2021 | 7.05 Million EUR | 33.6% |
| 2020 | 5.28 Million EUR | 45.12% |
| 2019 | 3.63 Million EUR | 283.64% |
| 2018 | -1.98 Million EUR | 63.91% |
| 2017 | -5.49 Million EUR | 13.79% |
| 2016 | -6.36 Million EUR | -2.52% |
| 2015 | -6.21 Million EUR | -58.11% |
| 2014 | -3.92 Million EUR | 27.74% |
| 2013 | -5.43 Million EUR | -90.83% |
| 2012 | -2.84 Million EUR | -76.01% |
| 2011 | -1.61 Million EUR | 38.93% |
| 2010 | -2.65 Million EUR | 18.71% |
| 2009 | -3.26 Million EUR | -363.52% |
| 2008 | -703.59 Thousand EUR | 66.26% |
| 2007 | -2.08 Million EUR | 59.35% |
| 2006 | -5.12 Million EUR | 14.01% |
| 2005 | -5.96 Million EUR | 22.42% |
| 2004 | -7.68 Million EUR | 9.67% |
| 2003 | -8.51 Million EUR | -7.85% |
| 2002 | -7.89 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q3 | 1.99 Million EUR | 448.66% |
| 2023 Q2 | -571.59 Thousand EUR | 0.0% |
| 2023 Q1 | -571.59 Thousand EUR | -202.57% |
| 2023 Q4 | 1.99 Million EUR | 0.0% |
| 2023 FY | 1.99 Million EUR | 257.6% |
| 2022 Q2 | 1.03 Million EUR | -86.42% |
| 2022 FY | 557.28 Thousand EUR | -92.1% |
| 2022 Q3 | 2.14 Million EUR | 107.18% |
| 2022 Q4 | 557.28 Thousand EUR | -73.98% |
| 2022 Q1 | 7.61 Million EUR | 7.89% |
| 2021 Q1 | 6 Million EUR | 13.6% |
| 2021 Q3 | 6.32 Million EUR | -5.52% |
| 2021 FY | 7.05 Million EUR | 33.6% |
| 2021 Q2 | 6.69 Million EUR | 11.52% |
| 2021 Q4 | 7.05 Million EUR | 11.61% |
| 2020 Q2 | 3.39 Million EUR | -10.9% |
| 2020 FY | 5.28 Million EUR | 45.12% |
| 2020 Q3 | 4.93 Million EUR | 45.41% |
| 2020 Q4 | 5.28 Million EUR | 7.09% |
| 2020 Q1 | 3.8 Million EUR | 4.59% |
| 2019 Q4 | 3.63 Million EUR | 46.53% |
| 2019 FY | 3.63 Million EUR | 283.64% |
| 2019 Q2 | 2.04 Million EUR | 388.01% |
| 2019 Q3 | 2.48 Million EUR | 21.48% |
| 2019 Q1 | -709.97 Thousand EUR | 64.18% |
| 2018 Q3 | -2.91 Million EUR | 35.24% |
| 2018 Q1 | -5.59 Million EUR | -1.87% |
| 2018 FY | -1.98 Million EUR | 63.91% |
| 2018 Q4 | -1.98 Million EUR | 32.01% |
| 2018 Q2 | -4.5 Million EUR | 19.54% |
| 2017 Q3 | -5.31 Million EUR | 6.55% |
| 2017 Q2 | -5.69 Million EUR | 14.23% |
| 2017 Q1 | -6.63 Million EUR | -4.19% |
| 2017 FY | -5.49 Million EUR | 13.79% |
| 2017 Q4 | -5.49 Million EUR | -3.24% |
| 2016 Q3 | -3.29 Million EUR | -59.17% |
| 2016 FY | -6.36 Million EUR | -2.52% |
| 2016 Q2 | -2.06 Million EUR | 66.4% |
| 2016 Q1 | -6.15 Million EUR | 0.91% |
| 2016 Q4 | -6.36 Million EUR | -93.47% |
| 2015 Q3 | -5.12 Million EUR | -11.2% |
| 2015 FY | -6.21 Million EUR | -58.11% |
| 2015 Q4 | -6.21 Million EUR | -21.28% |
| 2015 Q1 | -5.7 Million EUR | -45.21% |
| 2015 Q2 | -4.6 Million EUR | 19.26% |
| 2014 Q2 | -3.97 Million EUR | 30.44% |
| 2014 Q1 | -5.71 Million EUR | -5.11% |
| 2014 FY | -3.92 Million EUR | 27.74% |
| 2014 Q4 | -3.92 Million EUR | 13.15% |
| 2014 Q3 | -4.52 Million EUR | -13.79% |
| 2013 Q1 | -4.21 Million EUR | -47.98% |
| 2013 FY | -5.43 Million EUR | -90.83% |
| 2013 Q4 | -5.43 Million EUR | -31.54% |
| 2013 Q3 | -4.13 Million EUR | -17.08% |
| 2013 Q2 | -3.53 Million EUR | 16.27% |
| 2012 Q1 | -1.74 Million EUR | -7.81% |
| 2012 FY | -2.84 Million EUR | -76.01% |
| 2012 Q2 | -400.76 Thousand EUR | 77.04% |
| 2012 Q3 | -940.01 Thousand EUR | -134.56% |
| 2012 Q4 | -2.84 Million EUR | -203.17% |
| 2011 Q1 | -2.79 Million EUR | -5.6% |
| 2011 Q2 | -1.28 Million EUR | 54.23% |
| 2011 Q3 | 51.18 Thousand EUR | 103.99% |
| 2011 Q4 | -1.61 Million EUR | -3263.49% |
| 2011 FY | -1.61 Million EUR | 38.93% |
| 2010 Q4 | -2.65 Million EUR | -4.58% |
| 2010 FY | -2.65 Million EUR | 18.71% |
| 2010 Q1 | -6.37 Million EUR | -95.39% |
| 2010 Q2 | -3.24 Million EUR | 49.05% |
| 2010 Q3 | -2.53 Million EUR | 21.92% |
| 2009 FY | -3.26 Million EUR | -363.52% |
| 2009 Q2 | -1.93 Million EUR | 0.0% |
| 2009 Q4 | -3.26 Million EUR | 0.0% |
| 2008 FY | -703.59 Thousand EUR | 66.26% |
| 2007 FY | -2.08 Million EUR | 59.35% |
| 2006 FY | -5.12 Million EUR | 14.01% |
| 2005 FY | -5.96 Million EUR | 22.42% |
| 2004 FY | -7.68 Million EUR | 9.67% |
| 2003 FY | -8.51 Million EUR | -7.85% |
| 2002 FY | -7.89 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| aap Implantate AG | 4.01 Million EUR | 50.364% |
| Drägerwerk AG & Co. KGaA | 199.42 Million EUR | 99.001% |
| Drägerwerk AG & Co. KGaA | 199.42 Million EUR | 99.001% |
| elexxion AG | 4.07 Million EUR | 51.114% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | -11.69 Million EUR | 117.042% |
| Koninklijke Philips N.V. | 5.74 Billion EUR | 99.965% |
| Stratec SE | 107.83 Million EUR | 98.152% |
| Siemens Healthineers AG | -1 Billion EUR | 100.198% |